Budesonide
Product Images NDC 0781-7517

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 0781-7517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

Chemical structure of Budesonide as shown in the image, depicting the arrangement of atoms and bonds characteristic of this corticosteroid compound.*

FDA Label Image

Image 02

A line graph depicting the mean change from baseline in nighttime asthma symptoms over a 12-week period for different doses of Budesonide (0.25 mg, 0.5 mg, 1 mg once daily) compared to placebo. The x-axis represents time from baseline to week 12, and the y-axis shows the mean change in symptoms. The graph includes p-values for statistical significance of each Budesonide dose versus placebo.*

FDA Label Image

Image 03

A line graph showing the mean change from baseline in nighttime asthma symptoms over a 12-week period for three groups: placebo, 0.25 mg twice daily, and 0.5 mg twice daily doses. The x-axis represents time intervals from baseline to over 12 weeks, and the y-axis measures the mean change from baseline in symptoms, with values ranging from 0.0 to -0.6.*

FDA Label Image

Image 04

A line graph showing mean change from baseline in morning serum cortisol area under the curve (AUC) over several time intervals (baseline to weeks 10-12) for different doses of Budesonide (0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, 1 mg once daily) compared to placebo. Each dose is represented by distinct markers and lines, illustrating the cortisol level changes across the weeks, with corresponding p-values noted below the graph.*

FDA Label Image

Image 05

An instructional illustration showing hands preparing to open a blister pack containing multiple single-dose ampules or vials. The image focuses on demonstrating how to remove an individual dose from the sealed packaging, likely for a product related to Budesonide.*

FDA Label Image

Image 06

An instructional illustration showing a hand removing or opening a capped vial or container, with an arrow indicating a twisting motion. The image is part of a step-by-step guide, indicated by the number 2 in the top left corner.*

FDA Label Image

Image 07

An instructional illustration showing hands twisting the top off a small ampule or vial labeled with the number 3, likely demonstrating how to open the container for use with Budesonide.*

FDA Label Image

Image 08

An instructional illustration showing two hands using a device. One hand holds an inhaler or similar device, while the other hand holds a pill or capsule above the device's opening, indicating insertion or preparation for use.*

FDA Label Image

Image 09

The image shows the packaging label for Budesonide Inhalation Suspension 0.25 mg/2 mL by Sandoz Inc. It includes directions for use, packaging information stating 30 single-dose ampules per carton, and storage instructions. The label also highlights the product is for inhalation only and for prescription use (Rx only).*

FDA Label Image

Image 10

Budesonide Inhalation Suspension 0.5 mg/2 mL carton label by Sandoz Inc. The package contains 30 single-dose ampules intended for inhalation only. Directions on use include opening the ampule, gently shaking, and administering via nebulizer as directed. Storage instructions and warnings to keep out of reach of children are also provided.*

FDA Label Image

Image 11

Budesonide Inhalation Suspension 1 mg/2 mL carton packaging from Sandoz Inc, containing 30 single-dose ampules. The label specifies it is for inhalation only and prescription use (Rx only). Instructions for use of the ampules are included on the packaging, along with storage and handling details to keep the unopened ampules upright and protected from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.